DRMAW vs KHC
Dermata Therapeutics Inc. Warrant (DRMAW) versus Kraft Heinz Co (KHC) — a side-by-side from cached financials, not a winner call.
Dermata Therapeutics Inc. Warrant (DRMAW) common stock listed on NASDAQ.
Kraft Heinz Co (KHC) is a packaged foods company listed on US.
DRMAW does not have a complete income-statement cache yet.
Latest reported KHC revenue for 2026-06-27 was $12.31B. Net income was -$4.66B. KHC currently screens at market cap $31.55B and trailing P/E 12.2.
DRMAW currently screens at market cap $0. KHC currently screens at market cap $31.55B and trailing P/E 12.2.
Not investment advice. Open the DRMAW and KHC stock pages for the full models.
Not investment advice.